Smart nanocarriers for glioblastoma multiforme (GBM) treatment

Pharmacology, Toxicology and Pharmaceutical Science

• Nanocarrier 100%
• Glioblastoma 100%
• Neoplasm 78%
• Blood-Brain Barrier 35%
• Reactive Oxygen Metabolite 21%
• Dextran 21%
• Spermine 21%
• Malignant Neoplasm 21%
• Protein 14%
• Tumor Microenvironment 14%
• Hemoglobin 14%
• microRNA 14%
• Apoptosis 14%
• Agonist 14%
• Polymer 7%
• Diseases 7%
• Tumor Growth 7%
• Anticarcinogen 7%
• Ligand 7%
• Oligonucleotide 7%
• Vasculotropin 7%
• Drug 7%
• Gene Delivery 7%
• Hypoxia Inducible Factor 7%
• Life Expectancy 7%
• Glioma 7%
• Glucose Oxidase 7%
• Brain Cancer 7%
• Systemic Administration 7%
• Tenidap 7%
• Drug Delivery 7%
• Bradykinin 7%
• Biocompatibility 7%
• Controlled Release 7%
• Vascular Tumor 7%
• Antiangiogenic Therapy 7%

Neuroscience

• Glioblastoma Multiforme 100%
• Blood Brain Barrier 35%
• Gene 28%
• Reactive Oxygen Species 21%
• Dextran 21%
• In Vivo 14%
• Agonist 14%
• MicroRNA 14%
• Apoptosis 14%
• Protein 14%
• Hemoglobins 14%
• Gene Sequence 7%
• In Vitro 7%
• Cell Signaling 7%
• Ligand 7%
• Glioma 7%
• Oligonucleotide 7%
• Erythrocyte Membrane 7%
• Hypoxia-Inducible Factors 7%
• Angiogenesis 7%
• Gene Delivery 7%
• Glucose Oxidase 7%
• Bradykinin 7%
• Selectivity 7%
• Brain Cancer 7%

Biochemistry, Genetics and Molecular Biology

• Blood Brain Barrier 35%
• Gene Therapy 28%
• Dextran 21%
• Species 21%
• Apoptosis 14%
• Agonist 14%
• Protein 14%
• microRNA 14%
• Degradation 7%
• Gene Sequence 7%
• Cancer Cell 7%
• Oligonucleotide 7%
• Cross-Link 7%
• Electric Potential 7%
• MicroRNA 7%
• Signal Transduction 7%
• Angiogenesis 7%
• Growth 7%
• Surface Property 7%
• Vascular Endothelial Growth Factor 7%
• Biomimetics 7%
• Encapsulation 7%
• Erythrocyte Membrane 7%
• Gene Targeting 7%
• Hemoglobin 7%
• Glucose Oxidase 7%
• Life Expectancy 7%
• Comprehension 7%
• Attention 7%
• Self Concept 7%
• Bradykinin 7%
• Antisense 7%
• Hypoxia-Inducible Factors 7%